KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

LifeMD (LFMD) Short term Debt (2016 - 2025)

LifeMD filings provide 5 years of Short term Debt readings, the most recent being $12.0 million for Q2 2025.

On a quarterly basis, Short term Debt rose 88.85% to $12.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $12.0 million, a 88.85% increase, with the full-year FY2024 number at $8.4 million, changed N/A from a year prior.
Short term Debt hit $12.0 million in Q2 2025 for LifeMD, up from $11.6 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $12.0 million in Q2 2025 to a low of $4.0 million in Q1 2024.